Categories: HealthcareNews

Brian P. Smith Joins NAMSA as Chief Executive Officer; Brings 15+ Years of Life Sciences Leadership Expertise to Role

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

TOLEDO, Ohio, Feb. 24, 2025 /PRNewswire/ — NAMSA, a world-leading MedTech testing, clinical and regulatory consulting firm, announced today that Brian P. Smith has taken on the role of NAMSA’s next Chief Executive Officer. Most recently, Brian served as the Chairman and Chief Executive Officer of Ad-Tech Medical Instrument Corp., a leading US neuro-diagnostic company.  

Andre-Michel Ballester, NAMSA’s outgoing CEO, will transition back into his role as a managing partner of ARCHIMED, the healthcare-focused global private equity firm that holds a majority stake in NAMSA.  

Ballester led the search for a new CEO and notes: “Brian is globally recognized as a respected healthcare executive, having served in various leadership roles over the past 15 years as a Board Member, Operating Partner, Chairman of the Board, and Chief Executive Officer with extensive experience in operational, commercial, and innovation strategies.  Brian’s international experience, having lived and worked in Hong Kong, Shanghai, and Singapore, will be invaluable as we continue to expand our global footprint.”

Smith adds: “I am thrilled to join an organization with the history, reputation, and contribution to improved patient outcomes that NAMSA has repeatedly demonstrated for decades. I look forward to making my own contribution to this ongoing success story.”

NAMSA recently announced that it had signed a definitive agreement to purchase the US medical device testing operations of WuXi AppTec. That transaction is expected to close in late February and Smith will play an instrumental role in ensuring a smooth transition of WuXi AppTec’s business and customers to NAMSA.

About NAMSA
Helping medical device Sponsors improve healthcare since 1967, NAMSA is a leading global MedTech testing, clinical and regulatory consulting firm. With a deep pool of testing, clinical and regulatory experts, and in-depth therapeutic knowledge, NAMSA is dedicated to accelerating medical device product development. From preclinical and clinical research to medical device testing and regulatory compliance, NAMSA is the industry’s trusted partner for successful development and commercialization outcomes. Web: namsa.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/brian-p-smith-joins-namsa-as-chief-executive-officer-brings-15-years-of-life-sciences-leadership-expertise-to-role-302383602.html

SOURCE North American Science Associates, LLC

Staff

Recent Posts

Philips Future Health Index 2025 Report Highlights Significant Trust Gap in Healthcare AI Between Clinicians and Patients

AI in healthcare can address some of healthcare’s most pressing challenges, but trust barriers threaten…

21 minutes ago

New DiMe Seal Sets Benchmarks for Digital Health Products

Digital Medicine Society (DiMe) and Elevance Health collaborate to evaluate and elevate digital health software…

24 minutes ago

Novo Holdings appoints four new members to its Board of Directors further strengthening global perspectives and strategic capabilities

COPENHAGEN, Denmark, May 15, 2025 /PRNewswire/ -- Novo Holdings is pleased to announce the appointments…

24 minutes ago

Guelph General Hospital adds digital pathology to cloud service from Sectra–enables integrated diagnostics for improved patient care

LINKÖPING, Sweden and MISSISSAUGA, ON, May 15, 2025 /PRNewswire/ -- International medical imaging IT and…

24 minutes ago

Omnicell Announces New Products for Perioperative and Clinic Settings

RFID-Enabled Dispensing and Intelligent Inventory Management Software Aim to Unlock Greater Inventory Accuracy and Streamline…

12 hours ago

MARPAI REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

Marpai's turnaround momentum is building TAMPA, Fla., May 14, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or…

12 hours ago